Children's Hospital Los Angeles

Oncology & Cancer

When good immune cells turn bad

Investigators at the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles have identified new findings about an immune cell - called a tumor-associated macrophage - that promotes cancer instead ...

Oncology & Cancer

Identifying a new type of liver tumor

Investigators at Children's Hospital Los Angeles have succeeded in better defining a rare pediatric malignant liver disease—a necessary step in achieving an optimum treatment.

Medical research

Disruptive technology for the treatment of hemophilia

An international team of hematologists including Guy Young, MD, of Children's Hospital Los Angeles, has found that in patients with hemophilia A with inhibitors, a novel therapy called emicizumab, decreases incidence of bleeding ...

Oncology & Cancer

New biomarker assay detects neuroblastoma with greater sensitivity

Investigators at The Saban Research Institute of Children's Hospital Los Angeles have developed and tested a new biomarker assay for quantifying disease and detecting the presence of neuroblastoma even when standard evaluations ...

Diseases, Conditions, Syndromes

Inflammatory signature of nonalcoholic fatty liver disease

A team of investigators led by Rohit Kohli, MBBS, MS, of Children's Hospital Los Angeles, has identified key inflammatory cells involved in nonalcoholic fatty liver disease. Current treatment for the disorder involves changes ...

page 8 from 15